Drugs / CD133+ stem cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01025622 | Oct 2009 → Jun 2011 | cirrhosis of liver | University of Bologna | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD133+ stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01025622 ↗ |
| Modality | Cell therapy | “autologous highly purified CD133+ stem cells (SCs)” NCT01025622 ↗ |
| Route | Other | “will be infused through the hepatic artery” NCT01025622 ↗ |